Drug intelligence / Profile preview

Shenfu Yixin Granules

Development stage
Unknown
Lead developer
Buchang Pharmaceuticals
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Shenfu Yixin Granules (参附益心颗粒) is a Traditional Chinese Medicine (TCM) therapeutic developed by Shandong Buchang Pharmaceuticals for the treatment of cardiovascular conditions. The formulation is primarily indicated for chronic heart failure, specifically heart failure with reduced ejection fraction (HFrEF), and coronary heart disease, particularly in patients exhibiting the TCM "Yang Deficiency" pattern. Based on its name, the granules likely contain *Panax ginseng* (Ren Shen) and *Aconitum carmichaelii* (Fu Zi), which are traditionally used to restore Yang, tonify Qi, and improve cardiac output. The drug is currently undergoing Phase 2 clinical evaluation in China to assess its efficacy in improving cardiac function and symptoms in heart failure patients.

Brand names
Shenfu Yixin Granules
Other names
参附益心颗粒Shenfu Yixin

Beyond the preview

Go deeper on Shenfu Yixin Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenfu Yixin Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call